CAPLIN POINT LABORATORIES
Back to Balance Sheet
|
CAPLIN POINT LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹0.64 Cr | ₹0.64 Cr | ₹0.64 Cr | ₹0.71 Cr | ₹1.02 Cr |
What is the latest Contingent Liabilities ratio of CAPLIN POINT LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹0.64 Cr |
| Mar2024 | ₹0.64 Cr |
| Mar2023 | ₹0.64 Cr |
| Mar2022 | ₹0.71 Cr |
| Mar2021 | ₹1.02 Cr |
How is Contingent Liabilities of CAPLIN POINT LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.64 Cr | 0.00 | |
| Mar2024 | ₹0.64 Cr | 0.00 | |
| Mar2023 | ₹0.64 Cr | -9.86 | |
| Mar2022 | ₹0.71 Cr | -30.39 | |
| Mar2021 | ₹1.02 Cr | - | |
Compare Contingent Liabilities of peers of CAPLIN POINT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CAPLIN POINT LABORATORIES | ₹13,083.4 Cr | -5% | -13.1% | -21.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | -5% |
-13.1% |
-21.4% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses